Oxford Biomedica plc (LON:OXB) Not Doing Enough For Some Investors As Its Shares Slump 28% - Simply Wall St News
![Oxfordshire-based firm expands deal with US company | Thames Valley Inward Investment Portal | Foreign Investment Oxfordshire-based firm expands deal with US company | Thames Valley Inward Investment Portal | Foreign Investment](https://www.thamesvalley.co.uk/wp-content/uploads/2023/08/Oxford-Biomedica.png)
Oxfordshire-based firm expands deal with US company | Thames Valley Inward Investment Portal | Foreign Investment
![Kyverna Therapeutics and Oxford Biomedica Sign License and Supply Agreement for LentiVector® Platform Kyverna Therapeutics and Oxford Biomedica Sign License and Supply Agreement for LentiVector® Platform](https://mma.prnewswire.com/media/2204577/Kyverna_Therapeutics___Logo.jpg?p=facebook)
Kyverna Therapeutics and Oxford Biomedica Sign License and Supply Agreement for LentiVector® Platform
![Oxford Biomedica enters into agreement with Homology and proposes to raise proceeds of approx. £80 million Oxford Biomedica enters into agreement with Homology and proposes to raise proceeds of approx. £80 million](https://www.directorstalkinterviews.com/wp-content/uploads/2021/04/Oxford-Biomedica.jpg)
Oxford Biomedica enters into agreement with Homology and proposes to raise proceeds of approx. £80 million
![Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre](https://www.pharmaadvancement.com/wp-content/uploads/drug-development/15215/Vaccine-Oxford-Biomedica-Matthew-Duchars-Vaccines-Manufacturing-1000x570.jpg)